The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Sep. 01, 2026

Filed:

Oct. 22, 2021
Applicant:

Lunella Biotech, Inc., Ottawa, CA;

Inventors:

Michael P. Lisanti, Didsbury Village, GB;

Federica Sotgia, Didsbury Village, GB;

Marco Fiorillo, Manchester, GB;

Jussi Kangasmetsa, Cambridge, GB;

Assignee:

LUNELLA BIOTECH, INC., Ontario, CA;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07D 215/227 (2006.01); A61K 31/47 (2006.01); A61K 47/54 (2017.01); A61P 35/04 (2006.01); C12Q 1/6869 (2018.01); C12Q 1/6886 (2018.01);
U.S. Cl.
CPC ...
C07D 215/227 (2013.01); A61K 31/47 (2013.01); A61K 47/542 (2017.08); A61P 35/04 (2018.01); C12Q 1/6869 (2013.01); C12Q 1/6886 (2013.01); C12Q 2600/158 (2013.01);
Abstract

High ATP production by the mitochondrial ATP-synthase is a new therapeutic target for anti-cancer therapy, especially for preventing tumor progression. A mitochondrial-related gene signature for metastasis is described, which features the gamma-subunit of the mitochondrial ATP-synthase (ATP5F1C). Knock-down of ATP5F1C expression significantly reduces ATP-production, 3D anchorage-independent growth and cell migration. Administration of the Bedaquiline, or a Bedaquiline derivative with a fatty acid moiety, down-regulates ATP5F1C expression in vitro and prevents spontaneous metastasis in vivo. Mitochondrial ATP5F1C is a promising new biomarker and molecular target for future drug development, for the prevention of metastatic disease progression.


Find Patent Forward Citations

Quick Actions:

Lisanti, Michael. (2026). Mitochondrial atp inhibitors targeting the gamma subunit prevent metastasis (U.S. Patent No. 12723029). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/12723029

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…